Therapeutic efficiency of folated poly(ethylene glycol)-chitosan-graft-polyethylenimine-Pdcd4 complexes in H-ras12V mice with liver cancer

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1489-1498

  Kim, You Kyoung ^a   Minai Tehrani, Arash ^b   Lee, Jae Ho ^b   Cho, Chong Su ^b   Cho, Myung Haing ^b,c   Jiang, Hu Lin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Seoul National University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Efficiency; Folated poly(ethyleneglycol) chitosan graft polyethylenimine; Liver cancer; Safety; Targeted gene therapy

Indexed keywords

CHITOSAN DERIVATIVE; GREEN FLUORESCENT PROTEIN; POLY(ETHYLENE GLYCOL) CHITOSAN GRAFT POLYETHYLENIMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CELL SPECIFICITY; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOTOXICITY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CANCER; MALE; MOUSE; NONHUMAN; PDCD4 GENE; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

EFFICIENCY; FOLATED POLY(ETHYLENE GLYCOL)-CHITOSAN-GRAFT-POLYETHYLENIMINE; LIVER CANCER; SAFETY; TARGETED GENE THERAPY;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CHITOSAN; DNA; DRUG CARRIERS; FOLIC ACID; GENES, RAS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, TRANSGENIC; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RANDOM ALLOCATION; RNA-BINDING PROTEINS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84876253224     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S42949     Document Type: Article

References (34)

1. Nguyen TH, Ferry N. Liver gene therapy: advances and hurdles. Gene Ther. 2004;11 Suppl 1:S76-S84.
2. Huang PI, Lo WL, Cherng JY, Chien Y, Chiou GY, Chiou SH. Non-viral delivery of RNA interference targeting cancer cells in cancer gene therapy. Curr Gene Ther. 2012;12(4):275-284.
3. Rekha MR, Sharma CP. Polymers for gene delivery: current status and future perspectives. Recent Pat DNA Gene Seq. 2012;6(2):98-107.
4. Saranya N, Moorthi A, Saravanan S, Devi MP, Selvamurugan N. Chitosan and its derivatives for gene delivery. Int J Biol Macromol. 2011;48(2):234-238.
5. Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev. 2010;62(1):12-27.
6. Mansouri S, Cuie Y, Winnik F, et al. Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials. 2006;27(9):2060-2065.
7. Chan P, Kurisawa M, Chung JE, Yang YY. Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials. 2007;28(3):540-549.
8. Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 2001;70(3):399-421.
9. Kim TH, Jin H, Kim HW, Cho MH, Cho CS. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther. 2006;5(7):1723-1732.
10. Jiang HL, Kim YK, Arote R, et al. Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting. Int J Pharm. 2009;375(1-2):133-139.
11. Kim TH, Park IK, Nah JW, Choi YJ, Cho CS. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials. 2004;25(17):3783-3792.
12. Jiang HL, Kwon JT, Kim EM, et al. Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting. J Control Release. 2008;131(2):150-157.
13. Zhao XB, Lee RJ. Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv Drug Deliv Rev. 2004;56(8):1193-1204.
14. Hong G, Yuan R, Liang B, Shen J, Yang X, Shuai X. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs. Biomed Microdevices. 2008;10(5):693-700.
15. Jiang HL, Kim YK, Arote R, et al. Chitosan-graft-polyethylenimine as a gene carrier. J Control Release. 2007;117(2):273-280.
16. Kim EM, Jeong HJ, Park IK, et al. Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): in vitro and in vivo studies. J Control Release. 2005;108(2-3):557-567.
17. Jin H, Kim TH, Hwang SK, et al. Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol Cancer Ther. 2006;5(4):1041-1049.
18. Kim YK, Choi JY, Yoo MK, et al. Receptor-mediated gene delivery by folate-PEG-baculovirus in vitro. J Biotechnol. 2007;131(3):353-361.
19. McHugh M, Cheng YC. Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J Biol Chem. 1979;254(22):11312-11318.
20. Arote RB, Hwang SK, Lim HT, et al. The therapeutic efficiency of FP-PEA/TAM67gene complexes via folate receptor-mediated endocytosis in a xenograft mice model. Biomaterials. 2010;31(8):2435-2445.
21. Wang AG, Moon HB, Lee MR, et al. Gender-dependent hepatic alterations in H-ras12V transgenic mice. J Hepatol. 2005;43(5):836-844.
22. Hwang SK, Jin H, Kwon JT, et al. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther. 2007;14(18):1353-1361.
23. De Smedt SC, Demeester J, Hennink WE. Cationic polymer based gene delivery systems. Pharm Res. 2000;17(2):113-126.
24. Kunath K, von Harpe A, Fischer D, et al. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J Control Release. 2003;89(1):113-125.
25. Dubruel P, Dekie L, Christiaens B, et al. Poly-l-glutamic acid derivatives as multifunctional vectors for gene delivery. Part B. Biological evaluation. Biomacromolecules. 2003;4(5):1177-1183.
26. Namgung R, Kim J, Singha K, Kim CH, Kim WJ. Synergistic effect of low cytotoxic linear polyethylenimine and multiarm polyethylene glycol: study of physicochemical properties and in vitro gene transfection. Mol Pharm. 2009;6(6):1826-1735.
27. Zhang X, Pan SR, Hu HM, et al. Poly(ethylene glycol)-block-polyethylenimine copolymers as carriers for gene delivery: effects of PEG molecular weight and PEGylation degree. J Biomed Mater Res A. 2008;84(3):795-804.
28. Schipper NG, Varum KM, Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm Res. 1996;13(11):1686-1692.
29. Luo X, Feng M, Pan S, Wen Y, Zhang W, Wu C. Charge shielding effects on gene delivery of polyethylenimine/DNA complexes: PEGylation and phospholipid coating. J Mater Sci Mater Med. 2012;23(7):1685-1695.
30. Goldman CK, Soroceanu L, Smith N, et al. In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer. Nat Biotechnol. 1997;15(5):462-466.
31. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 1999;6(4):595-605.
32. Vader P, van der Aa LJ, Engbersen JF, Storm G, Schiffelers RM. Physicochemical and biological evaluation of siRNA polyplexes based on PEGylated poly(amido amine)s. Pharm Res. 2012;29(2):352-361.
33. Erbacher P, Zou S, Bettinger T, Steffan AM, Remy JS. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res. 1998;15(9):1332-1339.
34. Saikumar P, Dong Z, Mikhailov V, Denton M, Weinberg JM, Venkatachalam MA. Apoptosis: definition, mechanisms, and relevance to disease. Am J Med. 1999;107(5):489-506.